Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E A Fagan

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Annals of the Rheumatic Diseases|June 1, 1984
Coeliac disease and rheumatoid arthritisA L Parke, E A Fagan, V S Chadwick, et al.
Gut|June 1, 1980
Treatment of haemobilia by selective arterial embolisationE A Fagan, D J Allison, V S Chadwick, et al.
Human & Experimental Toxicology|March 1, 1991
Delayed calcium channel blockade with diltiazem reduces paracetamol hepatotoxicity in miceC D Deakin, C D Gove, E A Fagan, et al.
Hepatology (Baltimore, Md.)|July 1, 1991
Impaired binding properties of thyroxine-binding globulin in hepatocellular carcinoma and chronic liver diseaseW L Hutchinson, Y S White, E A Fagan, et al.
Journal of Hepatology|January 1, 1986
Fulminant hepatitis. An ultrastructural studyT F McCaul, E A Fagan, G Tovey, et al.
Gut|July 1, 1979
Rôle of calcitonin in diarrhoea associated with medullary carcinoma of the thyroidT M Cox, E A Fagan, C J Hillyard, et al.
Journal of Hepatology|July 1, 1991
Prognostic significance of pre-S2 antigen and antibody in fulminant hepatitis B. Evidence for heterogeneous serological responsesJ Brahm, E A Fagan, A Budkowska, et al.
Gut|September 1, 1982
Enumeration of lymphocyte populations defined by surface markers in the whole blood of patients with Crohn's diseaseE O Pepys, E A Fagan, G A Tennent, et al.
Journal of Medical Virology|June 1, 1987
Microbial structures in a patient with sporadic non-A, non-B fulminant hepatitis treated by liver transplantationE A Fagan, D S Ellis, B Portmann, et al.
Journal of Hepatology|January 1, 1986
Treatment of chronic HBeAg-positive hepatitis with acyclovir. A controlled trialP Guarascio, A P De Felici, D Migliorini, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Annals of the Rheumatic Diseases|June 1, 1984
Coeliac disease and rheumatoid arthritisA L Parke, E A Fagan, V S Chadwick, et al.
Gut|June 1, 1980
Treatment of haemobilia by selective arterial embolisationE A Fagan, D J Allison, V S Chadwick, et al.
Human & Experimental Toxicology|March 1, 1991
Delayed calcium channel blockade with diltiazem reduces paracetamol hepatotoxicity in miceC D Deakin, C D Gove, E A Fagan, et al.
Hepatology (Baltimore, Md.)|July 1, 1991
Impaired binding properties of thyroxine-binding globulin in hepatocellular carcinoma and chronic liver diseaseW L Hutchinson, Y S White, E A Fagan, et al.
Journal of Hepatology|January 1, 1986
Fulminant hepatitis. An ultrastructural studyT F McCaul, E A Fagan, G Tovey, et al.
Gut|July 1, 1979
Rôle of calcitonin in diarrhoea associated with medullary carcinoma of the thyroidT M Cox, E A Fagan, C J Hillyard, et al.
Journal of Hepatology|July 1, 1991
Prognostic significance of pre-S2 antigen and antibody in fulminant hepatitis B. Evidence for heterogeneous serological responsesJ Brahm, E A Fagan, A Budkowska, et al.
Gut|September 1, 1982
Enumeration of lymphocyte populations defined by surface markers in the whole blood of patients with Crohn's diseaseE O Pepys, E A Fagan, G A Tennent, et al.
Journal of Medical Virology|June 1, 1987
Microbial structures in a patient with sporadic non-A, non-B fulminant hepatitis treated by liver transplantationE A Fagan, D S Ellis, B Portmann, et al.
Journal of Hepatology|January 1, 1986
Treatment of chronic HBeAg-positive hepatitis with acyclovir. A controlled trialP Guarascio, A P De Felici, D Migliorini, et al.
Pageof 7